Validation of Thromboelastograph system (TEG®) in critically ill children admitted in the Pediatric Intensive Care Unit (PICU)

• Conditions: bloedstolling; clotting study / hemostatic study

• Registration Number: NL-OMON30976
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

•Arterial or central venous line in situ. Insertion of arterial or venous line must be indicated on clinical basis as a part of normal critical care management. No lines will be inserted just for study purposes.
•Written informed consent

Exclusion Criteria

•Dysfunctional arterial or central venous line - no free flowing sampling of blood possible

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Establishing intra- and inter observer variability of TEG® parameters (clotting<br /><br>time (r), clot kinetics (k and alfa angle) and clot strength (maximum<br /><br>amplitude)) in 0,5 ml kaolin activated whole blood of critically ill children. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Determination of TEG® manipulation duration and time to results of the<br /><br>different TEG® parameters.</p><br>